Organogenesis Holdings Inc. Quarterly Debt-to-equity in % from Q3 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Organogenesis Holdings Inc. quarterly Debt-to-equity history and growth rate from Q3 2017 to Q3 2024.
  • Organogenesis Holdings Inc. Debt-to-equity for the quarter ending September 30, 2024 was 64.6 %, a 4.84% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 64.6 -3.28 -4.84% Sep 30, 2024
Q2 2024 66.3 -4.29 -6.08% Jun 30, 2024
Q1 2024 65.8 -8.17 -11.1% Mar 31, 2024
Q4 2023 66.8 -9.95 -13% Dec 31, 2023
Q3 2023 67.8 -12.6 -15.7% Sep 30, 2023
Q2 2023 70.6 -13.6 -16.2% Jun 30, 2023
Q1 2023 73.9 -15.2 -17% Mar 31, 2023
Q4 2022 76.8 -18.4 -19.4% Dec 31, 2022
Q3 2022 80.5 -21 -20.7% Sep 30, 2022
Q2 2022 84.2 -41.6 -33.1% Jun 30, 2022
Q1 2022 89.1 -84.1 -48.5% Mar 31, 2022
Q4 2021 95.2 -151 -61.4% Dec 31, 2021
Q3 2021 101 -273 -72.9% Sep 30, 2021
Q2 2021 126 -368 -74.5% Jun 30, 2021
Q1 2021 173 -325 -65.3% Mar 31, 2021
Q4 2020 246 -264 -51.8% Dec 31, 2020
Q3 2020 375 -148 -28.4% Sep 30, 2020
Q2 2020 493 -92.3 -15.8% Jun 30, 2020
Q1 2020 499 +3.76K Mar 31, 2020
Q4 2019 511 +716 Dec 31, 2019
Q3 2019 523 +674 Sep 30, 2019
Q2 2019 586 +780 Jun 30, 2019
Q1 2019 -3.26K -2.8K -606% Mar 31, 2019
Q4 2018 -206 +60.6K +99.7% Dec 31, 2018
Q3 2018 -151 +4.63K +96.8% Sep 30, 2018
Q2 2018 -194 Jun 30, 2018
Q1 2018 -462 Mar 31, 2018
Q4 2017 -60.8K Dec 31, 2017
Q3 2017 -4.78K Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.